Meningococcal Disease
📧 Sign up to get email alerts when something new happens for Meningococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months [Phase 2]
A Phase 2 trial evaluated the immunogenicity and safety of a meningococcal ACYW135 polysaccharide conjugate vaccine in children aged 3 to 35…
-
FDA approval · 2022-01-29FDA Approved: RIFADIN IV — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for the IV formulation Rifadin (rifampin) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2022-01-19FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Rifampin from Chartwell RX, LLC under an ANDA. This confirms approval of a generic Rifampin prod…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers [Phase 3]
Phase 3 trial in European toddlers comparing MenACYW Conjugate Vaccine with two reference vaccines; the study has been completed and results…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age [Phase 3]
Phase 3 study comparing a quadrivalent meningococcal conjugate vaccine given as a single dose to a reference vaccine in participants aged 2 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of 1- and 2-dose regimens of MenACWY-TT (GSK134612) in toddlers, with persistence …
-
FDA approval · 2021-09-14FDA Approved: RIFAMPIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Rifampin under the ANDA. The approval indicates changes to the Rifampin pro…
-
FDA approval · 2021-09-13FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Rifampin (RIFAMPIN) submitted by Chartwell RX, LLC under ANDA065390.
-
FDA approval · 2021-09-13FDA Approved: RIFAMPIN — Supplemental Application (EPIC PHARMA, LLC)
The FDA approved a supplemental application for Rifampin from Epic Pharma, LLC. The action pertains to changes under the Rifampin ANDA 06415…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age [Phase 2, Phase 3]
Phase 2/3 trial evaluating lot-to-lot consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and comparing safety and immunogenicity to …
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4) [Phase 3]
Phase 3 study assessing the immune response to a booster dose of MenACYW Conjugate Vaccine given alone or with a licensed meningococcal sero…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults [Phase 1]
Phase 1 trial update for a meningococcal conjugate vaccine (MCV5) containing serogroups A, C, Y, W, and X in healthy adults; study completed…
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age [Phase 2]
Phase 2 trial investigating safety and immunogenicity of different formulations of MenACWY vaccine (GSK3536820A and Menveo) in healthy adole…
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Maternal Immunization With MenAfriVac™ [Phase 3]
Phase 3 clinical trial update for maternal immunization with MenAfriVac targeting meningitis/meningococcal disease.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine [Phase 3]
A Phase 3 trial update for a Group A and C meningococcal polysaccharide vaccine is reported, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B [Phase 4]
Phase 4 trial update evaluating antibody response to MenB vaccination in babies born prematurely; study completed.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered). [Phase 3]
Phase 3 trial evaluating a booster dose of MenACWY-TT (Nimenrix) given 10 years after initial vaccination in healthy 11-17-year-olds; study …
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Comparison of Two Meningococcal ACWY Conjugate Vaccines [Phase 2, Phase 3]
Phase 2/3 trial update comparing two meningococcal ACWY conjugate vaccines has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Hepatitis B Vaccination in Infants [Phase 4]
A Phase 4 clinical trial update on Hepatitis B vaccination in infants has completed, with sponsor Public Health England evaluating vaccinati…
-
FDA approval · 2020-09-02FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's supplemental application for rifampin (RIFAMPIN).
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158) [Phase 2]
Phase 2 trial update assessing 4-year antibody persistence and booster response after MenABCWY vaccination in adolescents/young adults who p…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years [Phase 2]
Phase 2 trial assessing immune interference from MenABCWY vaccine in healthy subjects aged 10-25; completed with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study
A completed clinical trial update for an infant study of the Meningococcal Quadrivalent CRM-197 Conjugate Vaccine, with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: South Australian Meningococcal B Vaccine Herd Immunity Study [Phase 4]
Phase 4 clinical trial update on a meningococcal B vaccine herd immunity study conducted in South Australia has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
A completed pregnancy registry study evaluating a meningococcal quadrivalent CRM-197 conjugate vaccine with results posted in 2019.